News & Publications for:

David Holtzman

The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging

Posted on October 20, 2016

Brian A. Gordon, Karl Friedrichsen, Matthew Brier, Tyler Blazey, Yi Su, Jon Christensen, Patricia Aldea, Jonathan McConathy, David M. Holtzman, Nigel J. Cairns, John C. Morris, Anne M. Fagan, Beau M. Ances and Tammie L. S. Benzinger: 2016 Brain, doi:10.1093/brain/aww139 Read More

Posted in: Clocks & Sleep, HPAN, Neurodegeneration, Publications Faculty: , , , ,

Tau and Ab imaging, CSF measures, and cognition in Alzheimer’s disease

Posted on October 20, 2016

Matthew R. Brier, Brian Gordon, Karl Friedrichsen, John McCarthy, Ari Stern, Jon Christensen, Christopher Owen, Patricia Aldea, Yi Su, Jason Hassenstab, Nigel J. Cairns, David M. Holtzman, Anne M. Fagan, John C. Morris, Tammie L. S. Benzinger, Beau M. Ances: 2016 Science Translational Medicine, 8(338). Read More

Posted in: Clocks & Sleep, HPAN, Neurodegeneration, Publications Faculty: , , , ,

Imaging and cerebrospinal fluid biomarkers in early preclinical alzheimer disease

Posted on September 30, 2016

Vlassenko AG, McCue L, Jasielec MS, et al: 2016 Annals of Neurology, 80(3), pp 379-387 Read More

Posted in: Clocks & Sleep, HPAN, Neurodegeneration, Publications Faculty: , , ,

Tau: From research to clinical development

Posted on June 13, 2016

Holtzman DM, Carrillo MC, Hendrix JA, et al: 2016 Alzheimer’s & Dementia doi:10.1016/j.jalz.2016.03.018 Read More

Posted in: Clocks & Sleep, HPAN, Neurodegeneration, Publications Faculty: